The authors found a reduced dementia hazard ratio for GLP-1 RAs of 0.47 (95% CI 0.25–0.86) and 0.89 (95% CI 0.86–0.93) in the trial and cohort data respectively. The gene discussed is GLP1R; the disease is dementia.